Back to Search Start Over

A DFT study for improving the photovoltaic performance of organic solar cells by designing symmetric non-fullerene acceptors by quantum chemical modification on pre-existed LC81 molecule.

Authors :
Zahoor A
Sadiq S
Khera RA
Essid M
Aloui Z
Alatawi NS
Ibrahim MAA
Hasanin THA
Waqas M
Source :
Journal of molecular graphics & modelling [J Mol Graph Model] 2023 Dec; Vol. 125, pp. 108613. Date of Electronic Publication: 2023 Aug 25.
Publication Year :
2023

Abstract

Minimizing the energy loss and improving the open circuit voltage of organic solar cells is still a primary concern for scientists working in this field. With the aim to enhance the photovoltaic performance of organic solar cells by minimizing energy loss and improving open circuit voltage, seven new acceptor molecules (LC1-LC7) are presented in this work. These molecules are designed by modifying the terminal acceptors of pre-existed "LC81" molecule based on an indacinodithiophene (IDT) fused core. The end-group modification approach is very fruitful in ameliorating the efficacy and optoelectric behavior of OSCs. The newly developed molecules presented remarkable improvements in performance-related parameters and optoelectronic properties. Among all designed molecules, LC7 exhibited the highest absorption maxima (λ <subscript>max</subscript>  = 869 nm) with the lowest band-gap (1.79 eV), lowest excitation energy (E <subscript>x</subscript>  = 1.42 eV), lowest binding energy, and highest excited state lifetime (0.41 ns). The newly designed molecules LC2, LC3, and LC4 exhibited remarkably improved Voc that was 1.84 eV, 1.82 eV, and 1.79 eV accordingly, compared to the LC81 molecule with V <subscript>oc</subscript> of 1.74 eV LC2 molecule showed significant improvement in fill factor compared to the previously presented LC81 molecule. LC2, LC6, and LC7 showed a remarkable reduction in energy loss by showing E <subscript>loss</subscript> values of 0.26 eV, 0.18 eV, and 0.25 eV than LC81 molecule (0.37 eV). These findings validate the supremacy of these developed molecules (especially LC2) as potential components of future OSCs.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2023 Elsevier Inc. All rights reserved.)

Subjects

Subjects :
Humans
Chlorhexidine
Osteosclerosis

Details

Language :
English
ISSN :
1873-4243
Volume :
125
Database :
MEDLINE
Journal :
Journal of molecular graphics & modelling
Publication Type :
Academic Journal
Accession number :
37659133
Full Text :
https://doi.org/10.1016/j.jmgm.2023.108613